Recent studies have radically changed our views of the development of acquired immunity during gestation and perinatal life. It is now apparent that there are considerable differences in the way the immune response matures in different species (Sterzl and Silverstein, 1967; Adinolfi and Wood, 1969; Solomon, 1971) . In mice and rats immune reactions are relatively immature even in the newborn. In the lamb, on the other hand, some degree of immunological competence is achieved about two-thirds of the way through fetal life (Silverstein and Prendergast, 1970) . In man, too, both humoral and cellular immunity are well developed before birth.
The Thymus
The first lymphoid organ to develop in the mammalian fetus is the thymus; there is evidence that in mammals and birds thymocytes differentiate from stem cells that have migrated into the epithelial rudiment from the yolk sac (Moore and Owen, 1967) . In some mammals neonatal thymectomy prevents the development of cellular immunity and depresses both homograft rejection and delayed hypersensitivity. Thymectomy also impairs the humoral antibody response to certain antigens (Hess, 1968) .
In the human fetus the thymus is an active lymphoid organ after 6 weeks of gestation. Lymphopoiesis in the thymus is intense and is independent of antigenic stimulation. However, recent observations have shown that at 20 weeks, the thymus of the human fetus may contain thymocytes which bind flagellins well before the fetal spleen or peripheral lymphocytes show the same degree of flagellin binding (Dwyer and MacKay, 1970) . Since Received 14 September 1971. flagellin tends to provoke a humoral antibody response, it is possible that in man the fetal thymus may itself produce humoral antibody or else that it influences the development of a diversity of antibody patterns (Burnet, 1970; Dwyer and MacKay, 1970) .
Antibody Production in the Fetus By using cultures of fetal tissues in vitro, van Furth, Schuit, and Hijmans (1965) showed that the human fetus is capable of producing immunoglobulins after the 20th week of gestation; immunofluorescent staining of fetal spleen cells confirmed the synthesis of both IgG and IgM. Peripheral fetal blood was also found to contain a few medium sized lymphocytes giving the staining reactions of these proteins.
However, plasma cells in the normal fetus remain scanty, even during the last month of gestation. This may be due to an environment which is protected from antigenic stimulation, since in congenital infections plasma cells are often present in fetal tissues. The presence of plasma cells in the liver of newborns with congenital syphilis was observed for the first time by Porcile (1904) . Silverstein and Lukes (1962) (1967) , while occasionally the synthesis of IgG has been found to be depressed (Soothill, Hayes, and Dudgeon, 1966) . Elevated levels of IgM globulins have also been detected in neonates with cytomegalic inclusion diseases (McCracken and Shinefield, 1965) and in infants with congenital infection with Toxoplasma gondii (Remington and Miller, 1966) .
Antibodies associated with IgM molecules, which are not transferred through the human placenta, have been demonstrated in normal newborns (Table) . These include anti-I cold agglutinins (Adinolfi, 1965) , IgM antibodies which cause reversible agglutination of trypsinized red cells (Mellbye, 1966) , and occasionally anti-A and anti-B agglutinins (Adinolfi and Wood, 1969) . Adinolfi and Wood (1969) .
Evidence for the synthesis of IgG during life in utero has been confirmed by the detection, in cord sera, of IgG molecules with genetic markers absent in the maternal serum (Vierucci, Varone, and Ingiulla, 1964; Martensson and Fudenberg, 1965; Martensson, 1966) . By means of highly specific antisera against allotypic IgG molecules, Gm specificities which are not present in maternal serum have been detected in newborn samples. The demonstration that through normal pregnancy some mothers produce anti-Gm antibodies has shown that the normal human fetus is capable of producing IgG molecules with antigenetic determinants inherited from the father; these molecules cross the human placenta and induce an immune response in the mother.
In a recent paper Wang et al (1970) have suggested that a specific fetal IgG is synthesized in man.
In contrast to the good evidence for the production of IgG and IgM on fetal life, IgA has been shown to be present in very low concentrations in the normal neonate (Heremans, 1960; West, Hong, and Holland, 1962; Adinolfi et al, 1966; Faulkner and Borella, 1970) . However, high levels of IgA have been detected in infants with congenital infections (Stiehm and Fudenberg, 1966) . IgD has not been detected in cord serum and its synthesis begins some time after birth (Rowe, Crabbe, and Turner, 1968) . On the other hand, IgE has been found in cord serum without obvious correlation between the level of this protein in maternal and cord samples. This suggests that this class of immunoglobulins is produced in utero.
Antibody Production in the Newborn
The results of the studies on the ontogeny of acquired immunity have an additional relevance to the use of immunization procedures in neonatal life. The literature of the antibody response in perinatal life has been extensively and critically analysed by Smith (1968) and Davies (1971) . Even premature infants appear to produce antibodies to Salmonella and typhoid-paratyphoid antigens (Smith, 1960; Fink et al, 1962) . Koprowski et al (1956) have also found that premature babies respond to live polio vaccine. However, the response of the newborn cannot always be predicted for a variety of reasons.
The control of the synthesis of specific antibodies during fetal and perinatal life has been studied by Gaisford (1958 and 1959) and Butler et al (1962) , who observed that the immune response of infants injected with poliomyelitis vaccine is often depressed in the presence of maternal antibodies. A comparable effect was noticed by Smith and Eitzman (1964) in infants intentionally stimulated with Salmonella antigens. Levi et al (1969) came to a similar conclusion after comparing the titre of maternal antibodies to pertussis, diphtheria, and tetanus antigens with the immune response to these antigens during perinatal life. They suggest that antibody synthesis is depressed in babies immunized shortly after birth in the presence of high levels of maternal antibodies. On the other hand, the synthesis of antibodies may be increased in newborn infants when the level of maternal antibodies of the same specificity is low.
Cellular Immunity in the Fetus Cellular immunity seems also to develop at an early stage of gestation, as judged by tests in vitro using transplantation antigens. Histocompatibility antigens of the major systems have been detected in human fetuses at an early stage of gestation (Ceppellini et al, 1971; Crome, Moffat, and Adinolfi, 1971) .
More important is the evidence that lymphocytes from fetuses more than 15 weeks' old are already competent to react in vitro against allogeneic stimuli. ability to produce a humoral and cellular response. Figure 1 shows the reaction of lymphocytes, ob-These include the ability to produce components of tained from two human fetuses 15 and 16 weeks old; complement and lysozyme. Some of the compo- these cells were cultured in the presence of HL-A antigens extracted from the skin of adult individuals (Crome et al, 1971) . The incorporation of 3H-thymidine was used as an index of the reactivity of the fetal cells (Adinolfi et al, 1967) ; there was evidence of a reaction to HL-A extracts taken from adult subjects and also to an extract prepared from a 20-week-old fetus. Ceppellini et al (1971) (Silverstein and Prendergast, 1970) .
Transplantation of allogeneic haemopoietic tissue into severely affected homozygote anaemic mice has been successfully achieved (Seller, 1970) ; similar tissue grafts in infants with inherited haemopoietic disorders will be more difficult to achieve because of the early maturation of cellular immunity during gestation in man.
Complement and Lysozyme
The immunological competence of the fetus and the newborn depends on many things besides the nents of complement (C3 and C4) have been shown to be synthesized at the beginning of the second trimester of gestation; all components of complement are present in fetuses that are 18 weeks old (Adinolfi, Gardner, and Wood, 1968; Adinolfi, 1970) .
Lysozyme is also present in fetuses more than 12 weeks old and in all newborns; the enzyme was detected in serum from 3 out of 9 fetuses between 9 and 12 weeks old and in all fetuses more than 24 weeks old. The levels of lysozyme in fetuses about 18 weeks old were similar to those observed in normal adults (Glynn, Martin, and Adinolfi, 1970) . When the amount of enzyme was compared in maternal and cord sera, it was found that the mean level was higher in the newborn samples (x= 12-59 jug/ml; SE = 0-53) than in the corresponding maternal sera (x=9-65 ,tg/ml; . No correlation was observed between the levels of the enzyme in maternal and cord samples; in several newborns the amount of the enzyme was from 3 to 5 88 Adinolfi and Lessof group.bmj.com on June 22, 2017 -Published by http://jmg.bmj.com/ Downloaded from times higher than that observed in the maternal serum (Adinolfi, Martin, and Glynn, 1971 ).
In mice, the level of lysozyme in newborn liver has been found to be ten times higher than that observed in maternal liver; the amount of the enzyme (expressed in ,tg/ml of tissue) decreases during the first 2 weeks of life and at 4 weeks is similar to that observed in normal adults ).
Fetal-maternal Immunological Reactions
In view of the early maturation of acquired immunity in the human fetus, it is not surprising that occasionally fetal immunological reactions against maternal antigens have been observed. Intrauterine iso-immunization caused by maternal IgA crossing the placenta was noticed in a newborn girl by Vyas, Levin, and Fudenberg (1970) . In recent years immunological reactions to maternal Gm antigens of IgG molecules have been described; maternal IgG globulins start to cross the placenta at about the third month of gestation (Mollison, 1951) and it might be expected that the infant would be tolerant to the maternal allotypic IgG molecules. However, the opposite happens; most children produce anti-Gm directed against maternal IgG during the first years of life (Steinberg and Wilson, 1963; Speiser, 1963; Speiser, 1966) . This is another example of the fact that foreign antigens may be present from an early stage of development without necessarily inducing a lasting immunological tolerance.
The maturation of cellular immunity at an early stage of gestation is probably responsible for the protection of the fetus against transplacental passage of bacteria. Brody, Oski, and Wallach (1968) observed a mitogenic response in vitro to E. coli by lymphocytes from neonates born to mothers who had documented infections of the urinary tract.
The maturation of fetal cellular immunity may have some relevance to fertility, although the observations so far published are not entirely explicable by current concepts. In a study of a Swedish population Seppala (1971) observed that matings between group A mother and group 0 father (pseudocompatible mating) produced more pregnancies and more children than did group A x group A matings (compatible); in neither case does the conceptus contain ABO antigens incompatible with the mother, although in the first case the fetus might in theory be capable of an immunological reaction against the mother.
Recently Bagshawe et al (1971) Antenatal reactions of the fetus to intrauterine infections are well documented and occasionally the formation of antibodies belonging to one class of immunoglobulins may be accompanied by depressed levels of immunoglobulins of other classes.
In neonatal life antibody production may be modified by maternal antibodies which have crossed the placenta.
In recent years, maternal immunological reactions to fetal antigens have been shown to be often associated with fetal immune reactions to maternal antigens; in some circumstances this type of reaction may favour the survival of the conceptus.
Because of the early maturation of cellular immunity in the human fetus, it is more difficult to achieve acceptance of tissue grafts in newborns with inherited haemopoietic disorders than in experimental animals.
